| Year |
Citation |
Score |
| 2018 |
Mc Causland FR, Claggett B, Burdmann EA, Chertow GM, Cooper ME, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, McMurray JJV, Parfrey P, Parving HH, Remuzzi G, Singh AK, et al. Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 30578152 DOI: 10.1053/J.Ajkd.2018.10.006 |
0.309 |
|
| 2017 |
Mc Causland FR, Claggett B, Pfeffer MA, Burdmann EA, Eckardt KU, Levey AS, McMurray JJV, Remuzzi G, Singh AK, Solomon SD, Toto RD, Parfrey P. Change in Hemoglobin Trajectory and Darbepoetin Dose Approaching End-Stage Renal Disease: Data from the Trial to Reduce Cardiovascular Events with Aranesp Therapy Trial. American Journal of Nephrology. 46: 488-497. PMID 29241199 DOI: 10.1159/000485326 |
0.318 |
|
| 2016 |
Mc Causland FR, Claggett B, Burdmann EA, Eckardt KU, Kewalramani R, Levey AS, McMurray JJ, Parfrey P, Remuzzi G, Singh AK, Solomon SD, Toto RD, Pfeffer MA. C-Reactive Protein and Risk of ESRD: Results From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 27646425 DOI: 10.1053/J.Ajkd.2016.07.022 |
0.342 |
|
| 2015 |
Parfrey PS, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Chertow GM. Lessons Learned from EVOLVE for Planning of Future Randomized Trials in Patients on Dialysis. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 26614406 DOI: 10.2215/Cjn.06370615 |
0.319 |
|
| 2015 |
Lewis EF, Claggett B, Parfrey PS, Burdmann EA, McMurray JJ, Solomon SD, Levey AS, Ivanovich P, Eckardt KU, Kewalramani R, Toto R, Pfeffer MA. Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus. American Heart Journal. 170: 322-9. PMID 26299230 DOI: 10.1016/J.Ahj.2015.05.008 |
0.355 |
|
| 2015 |
Moe SM, Chertow GM, Parfrey PS, Kubo Y, Block GA, Correa-Rotter R, Drüeke TB, Herzog CA, London GM, Mahaffey KW, Wheeler DC, Stolina M, Dehmel B, Goodman WG, Floege J, et al. Cinacalcet, FGF23 and Cardiovascular Disease in Hemodialysis: The EVOLVE Trial. Circulation. PMID 26059012 DOI: 10.1161/Circulationaha.114.013876 |
0.342 |
|
| 2015 |
Twomey JC, Barrett BJ, Way CY, Churchill DN, Parfrey PS. Psychometric properties of the Patient's Perception of Life on Hemodialysis Scale. Journal of Nursing Measurement. 23: 72-81. PMID 25985496 DOI: 10.1891/1061-3749.23.1.72 |
0.341 |
|
| 2015 |
Parfrey PS, Drüeke TB, Block GA, Correa-Rotter R, Floege J, Herzog CA, London GM, Mahaffey KW, Moe SM, Wheeler DC, Kubo Y, Dehmel B, Goodman WG, Chertow GM. The Effects of Cinacalcet in Older and Younger Patients on Hemodialysis: The Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial. Clinical Journal of the American Society of Nephrology : Cjasn. 10: 791-9. PMID 25710802 DOI: 10.2215/Cjn.07730814 |
0.351 |
|
| 2015 |
Stuckless S, Parfrey PS. Clinical genetic research 1: Bias. Methods in Molecular Biology (Clifton, N.J.). 1281: 333-48. PMID 25694320 DOI: 10.1007/978-1-4939-2428-8_20 |
0.311 |
|
| 2014 |
Williams CE, Curtis BM, Randell EW, Foley RN, Parfrey PS. Cardiac biomarkers and health-related quality of life in new hemodialysis patients without symptomatic cardiac disease. Canadian Journal of Kidney Health and Disease. 1: 16. PMID 26038709 DOI: 10.1186/2054-3581-1-16 |
0.321 |
|
| 2013 |
Watkins KE, Way CY, Gregory DM, LeDrew HM, Ludlow VC, Esplen MJ, Dowden JJ, Cox JE, Fitzgerald GW, Parfrey PS. Development and preliminary testing of the psychosocial adjustment to hereditary diseases scale. Bmc Psychology. 1: 7. PMID 25566359 DOI: 10.1186/2050-7283-1-7 |
0.319 |
|
| 2013 |
Negandhi AA, Hyde A, Dicks E, Pollett W, Younghusband BH, Parfrey P, Green RC, Savas S. MTHFR Glu429Ala and ERCC5 His46His Polymorphisms Are Associated with Prognosis in Colorectal Cancer Patients: Analysis of Two Independent Cohorts from Newfoundland Plos One. 8. PMID 23626689 DOI: 10.1371/Journal.Pone.0061469 |
0.305 |
|
| 2013 |
Zhu Y, Wu H, Wang PP, Savas S, Woodrow J, Wish T, Jin R, Green R, Woods M, Roebothan B, Buehler S, Dicks E, McLaughlin JR, Campbell PT, Parfrey PS. Dietary patterns and colorectal cancer recurrence and survival: a cohort study. Bmj Open. 3. PMID 23396503 DOI: 10.1136/Bmjopen-2012-002270 |
0.314 |
|
| 2013 |
Skali H, Lin J, Pfeffer MA, Chen CY, Cooper ME, McMurray JJ, Nissenson AR, Remuzzi G, Rossert J, Parfrey PS, Scott-Douglas NW, Singh AK, Toto R, Uno H, Ivanovich P. Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 61: 238-46. PMID 23159232 DOI: 10.1053/J.Ajkd.2012.08.043 |
0.329 |
|
| 2012 |
Savas S, Hyde A, Stuckless SN, Parfrey P, Younghusband HB, Green R. Serotonin transporter gene (SLC6A4) variations are associated with poor survival in colorectal cancer patients Plos One. 7. PMID 22911682 DOI: 10.1371/Journal.Pone.0038953 |
0.322 |
|
| 2012 |
Drüeke TB, Parfrey PS. Summary of the KDIGO guideline on anemia and comment: reading between the (guide)line(s). Kidney International. 82: 952-60. PMID 22854645 DOI: 10.1038/Ki.2012.270 |
0.323 |
|
| 2012 |
Chertow GM, Correa-Rotter R, Block GA, Drueke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Wheeler DC, Parfrey PS. Baseline characteristics of subjects enrolled in the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 27: 2872-9. PMID 22529163 DOI: 10.1093/Ndt/Gfr777 |
0.365 |
|
| 2012 |
Pei Y, Lan Z, Wang K, Garcia-Gonzalez M, He N, Dicks E, Parfrey P, Germino G, Watnick T. A missense mutation in PKD1 attenuates the severity of renal disease. Kidney International. 81: 412-7. PMID 22031115 DOI: 10.1038/Ki.2011.370 |
0.341 |
|
| 2012 |
McMurray JJV, Parfrey PS, Adamson JW, Aljama P, Berns JS, Bohlius J, Drüeke TB, Finkelstein FO, Fishbane S, Ganz T, MacDougall IC, McDonald RA, McMahon LP, Obrador GT, Strippoli GFM, et al. Kidney disease: Improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease Kidney International Supplements. 2: 279-335. DOI: 10.1038/Kisup.2012.37 |
0.351 |
|
| 2011 |
Skali H, Parving HH, Parfrey PS, Burdmann EA, Lewis EF, Ivanovich P, Keithi-Reddy SR, McGill JB, McMurray JJ, Singh AK, Solomon SD, Uno H, Pfeffer MA. Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation. 124: 2903-8. PMID 22104547 DOI: 10.1161/Circulationaha.111.030411 |
0.318 |
|
| 2011 |
Parfrey PS. Erythropoietin-stimulating agents in chronic kidney disease: a response to hyporesponsiveness. Seminars in Dialysis. 24: 495-7. PMID 21906165 DOI: 10.1111/J.1525-139X.2011.00949.X |
0.304 |
|
| 2011 |
Watkins KE, Way CY, Fiander JJ, Meadus RJ, Esplen MJ, Green JS, Ludlow VC, Etchegary HA, Parfrey PS. Lynch syndrome: barriers to and facilitators of screening and disease management. Hereditary Cancer in Clinical Practice. 9: 8. PMID 21899746 DOI: 10.1186/1897-4287-9-8 |
0.317 |
|
| 2011 |
Hopkins RB, Garg AX, Levin A, Molzahn A, Rigatto C, Singer J, Soltys G, Soroka S, Parfrey PS, Barrett BJ, Goeree R. Cost-effectiveness analysis of a randomized trial comparing care models for chronic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 1248-57. PMID 21617091 DOI: 10.2215/Cjn.07180810 |
0.308 |
|
| 2011 |
Win AK, Cleary SP, Dowty JG, Baron JA, Young JP, Buchanan DD, Southey MC, Burnett T, Parfrey PS, Green RC, Le Marchand L, Newcomb PA, Haile RW, Lindor NM, Hopper JL, et al. Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. International Journal of Cancer. Journal International Du Cancer. 129: 2256-62. PMID 21171015 DOI: 10.1002/Ijc.25870 |
0.303 |
|
| 2011 |
Watkins K, Way C, Stokes J, Meadus R, Esplen MJ, Green J, Ludlow V, Parfrey P. Hereditary non-polyposis colorectal cancer: barriers to and facilitators of screening and disease management Hereditary Cancer in Clinical Practice. 9: 39. DOI: 10.1186/1897-4287-9-S1-P39 |
0.33 |
|
| 2010 |
Woods MO, Younghusband HB, Parfrey PS, Gallinger S, McLaughlin J, Dicks E, Stuckless S, Pollett A, Bapat B, Mrkonjic M, de la Chapelle A, Clendenning M, Thibodeau SN, Simms M, Dohey A, et al. The genetic basis of colorectal cancer in a population-based incident cohort with a high rate of familial disease. Gut. 59: 1369-77. PMID 20682701 DOI: 10.1136/Gut.2010.208462 |
0.318 |
|
| 2010 |
Liu M, Shi S, Senthilnathan S, Yu J, Wu E, Bergmann C, Zerres K, Bogdanova N, Coto E, Deltas C, Pierides A, Demetriou K, Devuyst O, Gitomer B, Laakso M, ... ... Parfrey P, et al. Genetic variation of DKK3 may modify renal disease severity in ADPKD. Journal of the American Society of Nephrology : Jasn. 21: 1510-20. PMID 20616171 DOI: 10.1681/Asn.2010030237 |
0.34 |
|
| 2010 |
Wish TA, Hyde AJ, Parfrey PS, Green JS, Younghusband HB, Simms MI, Fontaine DG, Dicks EL, Stuckless SN, Gallinger S, McLaughlin JR, Woods MO, Green RC. Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1831-9. PMID 20570909 DOI: 10.1158/1055-9965.Epi-10-0055 |
0.325 |
|
| 2010 |
Parfrey PS. Editorial perspective. Should hemoglobin targets for anemic patients with chronic kidney disease be changed? American Journal of Nephrology. 31: 565-6. PMID 20501992 DOI: 10.1159/000313894 |
0.327 |
|
| 2010 |
Singh AK, Vecchio LD, Locatelli F, Parfrey PS, Yang M, Zhang M, Chen J, Mukherjee R, Zhang L, Lin S, Gu Y, Borchhardt KA, Diarra D, Sulzbacher I, Benesch T, et al. Title Page. Should Hemoglobin Targets for Anemic Patients with Chronic Kidney Disease Be Changed American Journal of Nephrology. 31: 551-551. DOI: 10.1159/000313890 |
0.326 |
|
| 2009 |
Kopciuk KA, Choi YH, Parkhomenko E, Parfrey P, McLaughlin J, Green J, Briollais L. Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models. Hereditary Cancer in Clinical Practice. 7: 16. PMID 19863818 DOI: 10.1186/1897-4287-7-16 |
0.327 |
|
| 2009 |
Shamseddin MK, Parfrey PS. Mechanisms of the cardiorenal syndromes. Nature Reviews. Nephrology. 5: 641-9. PMID 19786991 DOI: 10.1038/Nrneph.2009.156 |
0.345 |
|
| 2009 |
Barua M, Cil O, Paterson AD, Wang K, He N, Dicks E, Parfrey P, Pei Y. Family history of renal disease severity predicts the mutated gene in ADPKD. Journal of the American Society of Nephrology : Jasn. 20: 1833-8. PMID 19443633 DOI: 10.1681/Asn.2009020162 |
0.327 |
|
| 2009 |
Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P. Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis. Clinical Journal of the American Society of Nephrology : Cjasn. 4: 755-62. PMID 19339417 DOI: 10.2215/Cjn.02730608 |
0.363 |
|
| 2009 |
Foley RN, Curtis BM, Parfrey PS. Erythropoietin therapy, hemoglobin targets, and quality of life in healthy hemodialysis patients: A randomized trial Clinical Journal of the American Society of Nephrology. 4: 726-733. PMID 19339412 DOI: 10.2215/Cjn.04950908 |
0.308 |
|
| 2009 |
Green RC, Parfrey PS, Woods MO, Younghusband HB. Prediction of Lynch syndrome in consecutive patients with colorectal cancer. Journal of the National Cancer Institute. 101: 331-40. PMID 19244167 DOI: 10.1093/Jnci/Djn499 |
0.312 |
|
| 2009 |
Stuckless S, Parfrey PS. Bias in clinical studies of genetic diseases. Methods in Molecular Biology (Clifton, N.J.). 473: 171-86. PMID 19160738 DOI: 10.1007/978-1-59745-385-1_10 |
0.319 |
|
| 2009 |
Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, Parfrey P, Cramer B, Coto E, Torra R, San Millan JL, Gibson R, Breuning M, Peters D, Ravine D. Unified criteria for ultrasonographic diagnosis of ADPKD. Journal of the American Society of Nephrology : Jasn. 20: 205-12. PMID 18945943 DOI: 10.1681/Asn.2008050507 |
0.349 |
|
| 2008 |
Foley RN, Curtis BM, Parfrey PS. Hemoglobin targets and blood transfusions in hemodialysis patients without symptomatic cardiac disease receiving erythropoietin therapy Clinical Journal of the American Society of Nephrology. 3: 1669-1675. PMID 18922988 DOI: 10.2215/Cjn.02100508 |
0.34 |
|
| 2008 |
Ravani P, Parfrey P, Murphy S, Gadag V, Barrett B. Clinical research of kidney diseases IV: Standard regression models. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 23: 475-82. PMID 18182407 DOI: 10.1093/Ndt/Gfm880 |
0.31 |
|
| 2007 |
Ravani P, Parfrey P, Gadag V, Malberti F, Barrett B. Clinical research of kidney diseases III: principles of regression and modelling. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 22: 3422-30. PMID 18029371 DOI: 10.1093/Ndt/Gfm777 |
0.308 |
|
| 2007 |
Ravani P, Parfrey PS, Dicks E, Barrett BJ. Clinical research of kidney diseases II: problems of study design. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 22: 2785-94. PMID 17890738 DOI: 10.1093/Ndt/Gfm433 |
0.333 |
|
| 2007 |
Chertow GM, Pupim LB, Block GA, Correa-Rotter R, Drueke TB, Floege J, Goodman WG, London GM, Mahaffey KW, Moe SM, Wheeler DC, Albizem M, Olson K, Klassen P, Parfrey P. Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE): rationale and design overview. Clinical Journal of the American Society of Nephrology : Cjasn. 2: 898-905. PMID 17702710 DOI: 10.2215/Cjn.04381206 |
0.331 |
|
| 2007 |
Raptis S, Mrkonjic M, Green RC, Pethe VV, Monga N, Chan YM, Daftary D, Dicks E, Younghusband BH, Parfrey PS, Gallinger SS, McLaughlin JR, Knight JA, Bapat B. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer. Journal of the National Cancer Institute. 99: 463-74. PMID 17374836 DOI: 10.1093/Jnci/Djk095 |
0.318 |
|
| 2007 |
Pfeffer MA, Cooper ME, Burdmann EdA, deZeeuw D, Eckardt K, Levey A, McGill J, McMurray JJV, Parfrey P, Parving H, Remuzzi G, Singh AK, Solomon SD, Toto R. An Ongoing Study of Anemia Correction in Chronic Kidney Disease The New England Journal of Medicine. 356: 959-961. PMID 17329707 DOI: 10.1056/Nejmc066568 |
0.32 |
|
| 2007 |
Green RC, Green JS, Buehler SK, Robb JD, Daftary D, Gallinger S, McLaughlin JR, Parfrey PS, Younghusband HB. Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies. Familial Cancer. 6: 53-62. PMID 17039269 DOI: 10.1007/S10689-006-9104-X |
0.315 |
|
| 2007 |
Barrett BJ, Parfrey PS. Autosomal Dominant Polycystic Kidney Disease and End Stage Renal Disease Seminars in Dialysis. 4: 26-32. DOI: 10.1111/J.1525-139X.1991.Tb00408.X |
0.328 |
|
| 2006 |
Dicks E, Ravani P, Langman D, Davidson WS, Pei Y, Parfrey PS. Incident renal events and risk factors in autosomal dominant polycystic kidney disease: a population and family-based cohort followed for 22 years. Clinical Journal of the American Society of Nephrology : Cjasn. 1: 710-7. PMID 17699277 DOI: 10.2215/Cjn.01581105 |
0.359 |
|
| 2006 |
Rigatto C, Parfrey P. Therapy insight: management of cardiovascular disease in the renal transplant recipient. Nature Reviews Nephrology. 2: 514-526. PMID 16941044 DOI: 10.1038/Ncpneph0253 |
0.375 |
|
| 2005 |
Parfrey P. The Clinical Epidemiology of Contrast-Induced Nephropathy Cardiovascular and Interventional Radiology. 28. PMID 16419277 DOI: 10.1007/S00270-005-0196-8 |
0.367 |
|
| 2005 |
Shik J, Parfrey PS. The clinical epidemiology of cardiovascular disease in chronic kidney disease. Current Opinion in Nephrology and Hypertension. 14: 550-7. PMID 16205474 DOI: 10.1097/01.Mnh.0000170752.64150.88 |
0.332 |
|
| 2005 |
Curtis BM, Parfrey PS. Congestive heart failure in chronic kidney disease: Disease-specific mechanisms of systolic and diastolic heart failure and management Cardiology Clinics. 23: 275-284. PMID 16084277 DOI: 10.1016/J.Ccl.2005.04.002 |
0.353 |
|
| 2005 |
Parfrey PS, Foley RN, Wittreich BH, Sullivan DJ, Zagari MJ, Frei D. Double-blind comparison of full and partial anemia correction in incident hemodialysis patients without symptomatic heart disease. Journal of the American Society of Nephrology : Jasn. 16: 2180-9. PMID 15901766 DOI: 10.1681/Asn.2004121039 |
0.313 |
|
| 2005 |
Mix TC, Brenner RM, Cooper ME, de Zeeuw D, Ivanovich P, Levey AS, McGill JB, McMurray JJ, Parfrey PS, Parving HH, Pereira BJ, Remuzzi G, Singh AK, Solomon SD, Stehman-Breen C, et al. Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease. American Heart Journal. 149: 408-13. PMID 15864229 DOI: 10.1016/J.Ahj.2004.09.047 |
0.371 |
|
| 2005 |
Parfrey PS. Autosomal-recessive polycystic kidney disease. Kidney International. 67: 1638-48. PMID 15780130 DOI: 10.1111/J.1523-1755.2005.00246.X |
0.328 |
|
| 2005 |
Curtis BM, Levin A, Parfrey PS. Multiple risk factor intervention in chronic kidney disease: Management of cardiac disease in chronic kidney disease patients Medical Clinics of North America. 89: 511-523. PMID 15755465 DOI: 10.1016/J.Mcna.2004.12.002 |
0.364 |
|
| 2005 |
Hodgkinson KA, Parfrey PS, Bassett AS, Kupprion C, Drenckhahn J, Norman MW, Thierfelder L, Stuckless SN, Dicks EL, McKenna WJ, Connors SP. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD5). Journal of the American College of Cardiology. 45: 400-8. PMID 15680719 DOI: 10.1016/J.Jacc.2004.08.068 |
0.308 |
|
| 2005 |
Paterson AD, Magistroni R, He N, Wang K, Johnson A, Fain PR, Dicks E, Parfrey P, St George-Hyslop P, Pei Y. Progressive loss of renal function is an age-dependent heritable trait in type 1 autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 16: 755-62. PMID 15677307 DOI: 10.1681/Asn.2004090758 |
0.356 |
|
| 2005 |
Fan Y, Green JS, Ross AJ, Beales PL, Parfrey PS, Davidson WS. Linkage disequilibrium mapping in the Newfoundland population: a re-evaluation of the refinement of the Bardet-Biedl syndrome 1 critical interval. Human Genetics. 116: 62-71. PMID 15517396 DOI: 10.1007/S00439-004-1184-9 |
0.306 |
|
| 2003 |
Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, Van Dijk M, Breuning M, Peters D, Bogdanova N, et al. Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 14: 1164-74. PMID 12707387 DOI: 10.1097/01.Asn.0000061774.90975.25 |
0.379 |
|
| 2003 |
Parfrey PS. THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Introduction Seminars in Dialysis. 16: 83-84. PMID 12641869 DOI: 10.1046/J.1525-139X.2003.16022.X |
0.333 |
|
| 2003 |
Rigatto C, Foley R, Jeffery J, Negrijn C, Tribula C, Parfrey P. Electrocardiographic Left Ventricular Hypertrophy in Renal Transplant Recipients: Prognostic Value and Impact of Blood Pressure and Anemia Journal of the American Society of Nephrology. 14: 462-468. PMID 12538748 DOI: 10.1097/01.Asn.0000043141.67989.39 |
0.365 |
|
| 2001 |
Rigatto C, Parfrey P. Factors governing cardiovascular risk in the patient with a failing renal transplant. Peritoneal Dialysis International. 21: 275-279. DOI: 10.1177/089686080102103S48 |
0.329 |
|
| 2000 |
Parfrey PS. Cardiac disease in dialysis patients: diagnosis, burden of disease, prognosis, risk factors and management. Nephrology Dialysis Transplantation. 15: 58-68. PMID 11073277 DOI: 10.1093/Ndt/15.Suppl_5.58 |
0.337 |
|
| 2000 |
Katsanis N, Beales PL, Woods MO, Lewis RA, Green JS, Parfrey PS, Ansley SJ, Davidson WS, Lupski JR. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nature Genetics. 26: 67-70. PMID 10973251 DOI: 10.1038/79201 |
0.301 |
|
| 2000 |
Foley RN, Parfrey PS, Morgan J, Barré PE, Campbell P, Cartier P, Coyle D, Fine A, Handa P, Kingma I, Lau CY, Levin A, Mendelssohn D, Muirhead N, Murphy B, et al. Effect of hemoglobin levels in hemodialysis patients with asymptomatic cardiomyopathy. Kidney International. 58: 1325-35. PMID 10972697 DOI: 10.1046/J.1523-1755.2000.00289.X |
0.31 |
|
| 2000 |
Murphy SW, Foley RN, Barrett BJ, Kent GM, Morgan J, Barré P, Campbell P, Fine A, Goldstein MB, Handa SP, Jindal KK, Levin A, Mandin H, Muirhead N, Richardson RM, ... Parfrey PS, et al. Comparative mortality of hemodialysis and peritoneal dialysis in Canada. Kidney International. 57: 1720-6. PMID 10760108 DOI: 10.1046/J.1523-1755.2000.00017.X |
0.324 |
|
| 1999 |
Murphy ST, Parfrey PS. Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit. Current Opinion in Nephrology and Hypertension. 8: 573-578. PMID 10541220 DOI: 10.1097/00041552-199909000-00007 |
0.355 |
|
| 1999 |
Foley RN, Parfrey PS. Anemia as a risk factor for cardiac disease in dialysis patients Seminars in Dialysis. 12: 84-86. DOI: 10.1046/J.1525-139X.1999.00013.X |
0.34 |
|
| 1999 |
Parfrey PS. Introduction: CARDIAC DISEASE IN DIALYSIS PATIENTS: INTRODUCTION Seminars in Dialysis. 12: 61-61. DOI: 10.1046/J.1525-139X.1999.00009.X |
0.327 |
|
| 1999 |
Parfrey PS. Pathogenesis of Cardiac Disease in Dialysis Patients: PATHOGENESIS OF CARDIAC DISEASE IN DIALYSIS PATIENTS Seminars in Dialysis. 12: 62-68. DOI: 10.1046/J.1525-139X.1999.00008.X |
0.328 |
|
| 1998 |
Murphy SW, Foley RN, Parfrey PS. Screening and treatment for cardiovascular disease in patients with chronic renal disease. American Journal of Kidney Diseases. 32. PMID 9820475 DOI: 10.1053/Ajkd.1998.V32.Pm9820475 |
0.373 |
|
| 1998 |
Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. American Journal of Kidney Diseases. 32. PMID 9820470 DOI: 10.1053/Ajkd.1998.V32.Pm9820470 |
0.344 |
|
| 1998 |
O'Dea D, Murphy S, Hefferton D, Parfrey P. Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: A population-based study American Journal of Kidney Diseases. 32: 794-801. PMID 9820449 DOI: 10.1016/S0272-6386(98)70135-0 |
0.38 |
|
| 1998 |
Cole E, Keown P, Landsberg D, Halloran P, Shoker A, Rush D, Jeffrey J, Russell D, Stiller C, Muirhead N, Paul L, Zaltzman J, Loertscher R, Daloze P, Dandavino R, ... ... Parfrey P, et al. Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group. Transplantation. 65: 505-510. PMID 9500624 DOI: 10.1097/00007890-199802270-00009 |
0.314 |
|
| 1997 |
Foley RN, Culleton BF, Parfrey PS, Harriett JD, Kent GM, Murray DC, Barre PE. Cardiac disease in diabetic end-stage renal disease Diabetologia. 40: 1307-1312. PMID 9389423 DOI: 10.1007/S001250050825 |
0.341 |
|
| 1997 |
Barrett BJ, Parfrey PS, Morgan J, Barré P, Fine A, Goldstein MB, Handa SP, Jindal KK, Kjellstrand CM, Levin A, Mandin H, Muirhead N, Richardson RM. Prediction of early death in end-stage renal disease patients starting dialysis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 29: 214-22. PMID 9016892 DOI: 10.1016/S0272-6386(97)90032-9 |
0.359 |
|
| 1997 |
Parfrey PS, Foley RN. Risk Factors for Cardiac Dysfunction in Dialysis Patients: Implications for Patient Care Seminars in Dialysis. 10: 137-141. DOI: 10.1111/J.1525-139X.1997.Tb00471.X |
0.318 |
|
| 1996 |
Murphy SW, Parfrey PS. Screening for cardiovascular disease in dialysis patients. Current Opinion in Nephrology and Hypertension. 5: 532-540. PMID 8979003 DOI: 10.1097/00041552-199611000-00014 |
0.351 |
|
| 1996 |
Culleton B, Parfrey PS. Cardiovascular Risk in Continuous Ambulatory Peritoneal Dialysis Patients Peritoneal Dialysis International. 16: 10-12. DOI: 10.1177/089686089601600102 |
0.32 |
|
| 1995 |
Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: Prevalence, incidence, prognosis and risk factors Kidney International. 47: 884-890. PMID 7752588 DOI: 10.1038/Ki.1995.132 |
0.363 |
|
| 1995 |
Parfrey PS, Harnett JD, Foley RN, Kent GM, Murray DC, Barre PE, Guttmann RD. Impact of renal transplantation on uremic cardiomyopathy Transplantation. 60: 908-914. DOI: 10.1097/00007890-199511000-00005 |
0.325 |
|
| 1994 |
Foley RN, Parfrey PS, Hefferton D, Singh I, Simms A, Barrett BJ. Advance prediction of early death in patients starting maintenance dialysis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 23: 836-45. PMID 8203366 DOI: 10.1016/S0272-6386(12)80137-5 |
0.343 |
|
| 1994 |
Foley RN, Parfrey PS. Risk factors for cardiac morbidity and mortality in dialysis patients. Current Opinion in Nephrology and Hypertension. 3: 608-614. PMID 7881984 DOI: 10.1097/00041552-199411000-00008 |
0.355 |
|
| 1994 |
Barrett BJ, Foley R, Morgan J, Hefferton D, Parfrey P. Differences in hormonal and renal vascular responses between normotensive patients with autosomal dominant polycystic kidney disease and unaffected family members. Kidney International. 46: 1118-23. PMID 7861706 DOI: 10.1038/Ki.1994.374 |
0.315 |
|
| 1994 |
Parfrey PS, Harnett JD. The management of cardiac disease in chronic uremia. Current Opinion in Nephrology and Hypertension. 3: 145-154. PMID 7842264 DOI: 10.1097/00041552-199403000-00004 |
0.333 |
|
| 1993 |
Parfrey PS. Cardiac and Cerebrovascular Disease in Chronic Uremia American Journal of Kidney Diseases. 21: 77-80. PMID 8418631 DOI: 10.1016/S0272-6386(12)80726-8 |
0.37 |
|
| 1993 |
Parfrey PS. Hereditary renal diseases. Current Opinion in Nephrology and Hypertension. 2: 192-200. PMID 7922177 DOI: 10.1097/00041552-199303000-00004 |
0.333 |
|
| 1992 |
Bear JC, Parfrey PS, Morgan JM, Martin CJ, Cramer BC. Autosomal dominant polycystic kidney disease: new information for genetic counselling. American Journal of Medical Genetics. 43: 548-553. PMID 1605247 DOI: 10.1002/Ajmg.1320430309 |
0.32 |
|
| 1992 |
Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, Fay WP, Goldstein MB, Jindal K, Mandin H, McKenzie JK, Muirhead N, Parfrey PS, Posen GA, Slaughter D, et al. Canadian Hemodialysis Morbidity Study American Journal of Kidney Diseases. 19: 214-234. PMID 1553966 DOI: 10.1016/S0272-6386(13)80002-9 |
0.325 |
|
| 1990 |
Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, Gault MH, Churchill DN, Singh M, Hewitt R, Somlo S. The diagnosis and prognosis of autosomal dominant polycystic kidney disease. The New England Journal of Medicine. 323: 1085-90. PMID 2215575 DOI: 10.1056/Nejm199010183231601 |
0.33 |
|
| 1990 |
Parfrey PS, Griffiths SM, Harnett JD, Taylor R, King A, Hand J, Barre PE. Outcome of congestive heart failure, dilated cardiomyopathy, hypertrophic hyperkinetic disease, and ischemic heart disease in dialysis patients. American Journal of Nephrology. 10: 213-21. PMID 2143353 DOI: 10.1159/000168084 |
0.328 |
|
| 1990 |
Parfrey PS, Harnett JD, Griffiths SM, Taylor R, Hand J, King A, Barre PE. The clinical course of left ventricular hypertrophy in dialysis patients. Nephron. 55: 114-20. PMID 2141918 DOI: 10.1159/000185937 |
0.329 |
|
| 1986 |
Farge D, Parfrey PS, Forbes RDC, Dandavino R, Guttmann RD. Reduction of azathioprine in renal transplant patients with chronic hepatitis. Transplantation. 41: 55-59. PMID 3510495 DOI: 10.1097/00007890-198601000-00011 |
0.316 |
|
| 1985 |
Cramer BC, Parfrey PS, Hutchinson TA, Baran D, Melanson DM, Ethier RE, Seely JF. Renal Function Following Infusion of Radiologic Contrast Material: A Prospective Controlled Study Jama Internal Medicine. 145: 87-89. DOI: 10.1001/Archinte.1985.00360010115018 |
0.318 |
|
| 1984 |
Parfrey PS, Forbes RDc, Hutchinson TA, Beaudoin JG, Dauphinee WD, Hollomby DJ, Guttmann RD. The clinical and pathological course of hepatitis B liver disease in renal transplant recipients. Transplantation. 37: 461-466. PMID 6375001 DOI: 10.1097/00007890-198405000-00008 |
0.301 |
|
| Show low-probability matches. |